DEFB125 (defensin beta 125) is a member of the beta-defensin family with demonstrated antibacterial activity and roles in innate immunity. At the molecular level, DEFB125 functions through membrane destabilization mechanisms to kill pathogenic organisms 1. The gene is regulated by innate immune signaling pathways; specifically, NLRX1-mediated suppression of NF-κB activation negatively regulates DEFB125 expression during enterohemorrhagic Escherichia coli infection, with DEFB125 upregulation occurring upon pathway inhibition 1. DEFB125 shows region-specific expression patterns in the male reproductive tract, with relatively high expression detected in the corpus epididymis, suggesting a role in the local immune environment during spermatozoal maturation 2. From a clinical perspective, DEFB125 is located within the 20p13 region, which is amplified in tongue cancer tissues from young adults with disease recurrence, indicating potential involvement in cancer-associated genomic alterations 3. The gene's functional role in anti-microbial defense through antibacterial and cell-killing activities positions it as part of the innate immune response system, though further investigation is needed to fully characterize its contributions to tissue-specific immunity and cancer biology.